Search Results - "Minnier, Tami E"

Evolving Real-World Effectiveness of Monoclonal Antibodies for Treatment of COVID-19 : A Cohort Study by Kip, Kevin E, McCreary, Erin K, Collins, Kevin, Minnier, Tami E, Snyder, Graham M, Garrard, William, McKibben, Jeffrey C, Yealy, Donald M, Seymour, Christopher W, Huang, David T, Bariola, J Ryan, Schmidhofer, Mark, Wadas, Richard J, Angus, Derek C, Kip, Paula L, Marroquin, Oscar C

“…Treatment guidelines and U.S. Food and Drug Administration emergency use authorizations (EUAs) of monoclonal antibodies (mAbs) for treatment of high-risk…”
Get full text

COVID-19 contagious health care personnel 5-day early return-to-work program by Wagester, Suzanne, Smith, Patricia, Lutz, Calvin T., Chung, Ashley, Tanis, Mark D., O'Hare, Colleen, Mallon, Abbie, Minnier, Tami E., Silvaggio, Teresa, Ruscetti, Amy, Chrisman, Maddie, Zapf, Rachel L., Kip, Paula L., Snyder, Graham M.

“…•Employees were eligible to return-to-work after 5 days of isolation.•46.8% (161/344) of employees who tested negative were eligible to return-to-work on day…”
Get full text

Evaluation of Bebtelovimab for Treatment of Covid-19 During the SARS-CoV-2 Omicron Variant Era by McCreary, Erin K, Kip, Kevin E, Collins, Kevin, Minnier, Tami E, Snyder, Graham M, Steiner, Ashley, Meyers, Russell, Borneman, Tina, Adam, Michelle, Thurau, Lauren, Yealy, Donald M, Huang, David T, Bariola, J Ryan, Schmidhofer, Mark, Wadas, Richard J, Angus, Derek C, Kip, Paula L, Marroquin, Oscar C

“…Abstract Background Monoclonal antibody (mAb) treatment is associated with decreased risk of hospitalization and death in high-risk outpatients with mild to…”
Get full text

Implementing a Discharge Follow-up Phone Call Program Reduces Readmission Rates in an Integrated Health System by Lukanski, Amy, Watters, Shelley, Bilderback, Andrew L, Buchanan, Dan, Hodges, Jacob C, Burwell, David, Triola, Amy, Marroquin, Oscar C, Martin, Susan C, Zapf, Rachel L, Kip, Paula L, Minnier, Tami E

“…In this study, we sought to determine the effect of implementing a large-scale discharge follow-up phone call program on hospital readmission rates. Previous…”
Get full text

COVID-19 Contagious Healthcare Personnel 5-Day Early Return-to-Work Program by Wagester, Suzanne, Smith, Patricia, Lutz, Calvin T., Chung, Ashley, Tanis, Mark D., O'Hare, Colleen, Mallon, Abbie, Minnier, Tami E., Silvaggio, Teresa, Ruscetti, Amy, Chrisman, Maddie, Zapf, Rachel L., Kip, Paula L., Snyder, Graham M.

Get full text

Effectiveness of Casirivimab-Imdevimab and Sotrovimab During a SARS-CoV-2 Delta Variant Surge: A Cohort Study and Randomized Comparative Effectiveness Trial by Huang, David T, McCreary, Erin K, Bariola, J Ryan, Minnier, Tami E, Wadas, Richard J, Shovel, Judith A, Albin, Debbie, Marroquin, Oscar C, Kip, Kevin E, Collins, Kevin, Schmidhofer, Mark, Wisniewski, Mary Kay, Nace, David A, Sullivan, Colleen, Axe, Meredith, Meyers, Russell, Weissman, Alexandra, Garrard, William, Peck-Palmer, Octavia M, Wells, Alan, Bart, Robert D, Yang, Anne, Berry, Lindsay R, Berry, Scott, Crawford, Amy M, McGlothlin, Anna, Khadem, Tina, Linstrum, Kelsey, Montgomery, Stephanie K, Ricketts, Daniel, Kennedy, Jason N, Pidro, Caroline J, Nakayama, Anna, Zapf, Rachel L, Kip, Paula L, Haidar, Ghady, Snyder, Graham M, McVerry, Bryan J, Yealy, Donald M, Angus, Derek C, Seymour, Christopher W

“…The effectiveness of monoclonal antibodies (mAbs), casirivimab-imdevimab and sotrovimab, is unknown in patients with mild to moderate COVID-19 caused by the…”
Get full text

The comparative effectiveness of COVID-19 monoclonal antibodies: A learning health system randomized clinical trial by McCreary, Erin K., Bariola, J. Ryan, Minnier, Tami E., Wadas, Richard J., Shovel, Judith A., Albin, Debbie, Marroquin, Oscar C., Kip, Kevin E., Collins, Kevin, Schmidhofer, Mark, Wisniewski, Mary Kay, Nace, David A., Sullivan, Colleen, Axe, Meredith, Meyers, Russell, Weissman, Alexandra, Garrard, William, Peck-Palmer, Octavia M., Wells, Alan, Bart, Robert D., Yang, Anne, Berry, Lindsay R., Berry, Scott, Crawford, Amy M., McGlothlin, Anna, Khadem, Tina, Linstrum, Kelsey, Montgomery, Stephanie K., Ricketts, Daniel, Kennedy, Jason N., Pidro, Caroline J., Haidar, Ghady, Snyder, Graham M., McVerry, Bryan J., Yealy, Donald M., Angus, Derek C., Nakayama, Anna, Zapf, Rachel L., Kip, Paula L., Seymour, Christopher W., Huang, David T.

“…Monoclonal antibodies (mAb) that neutralize SARS-CoV-2 decrease hospitalization and death compared to placebo in patients with mild to moderate COVID-19;…”
Get full text